Showing 2001 - 2020 de 6607 results
The "la Caixa" Foundation will allocate €150,000 to develop this project led by Eugenia Martínez Hernández, from the Pathogenesis of autoimmune neuro1
Last Tuesday, 15 October 2024, IDIBAPS received a visit from thirty people, most of them patients with liver cancer under treatment at the Hospital C1
The retreat was used to consider IDIBAPS’ challenges and opportunities and to make proposals for its 2025-2028 Strategic Plan.
It is the first time that a public research foundation reaches this figure anywhere in Spain.
On Sunday 20 October, an extraordinary session was held to elect Dr. Eduard Vieta, head of the Psychiatry and Psychology Service at the Hospital Clín1
The study analysed head impacts among professional footballers in World Cup matches over a period of 50 years, and observed a significant number of t1
Five researchers from the Clínic-IDBAPS were recognized with various grants worth a total of €122,000 at the Spanish Society of Medical Oncology (SEO1
The governing and coordinating body of the administrations involved is set up to specify the key aspects in terms of uses, financing, urban transform1
Metabolic fatty liver disease affects almost 30% of the population, and 80% of those who are obese. The disease has no cure, but its progression can1
Dr. Joan Giralt has been part of the Clínic family for almost 17 years now… and for 12 years has been a professor of ophthalmology at the Faculty of1
A Clínic-IDIBAPS research team is participating in the European Foreum-RA-Flare project, which aims to predict relapses in patients with rheumatoid a1
IDIBAPS’ Inflammation and repair in respiratory diseases group is part of the collaborative RESPIRE-EXCEL project coordinated by Martijn Nawijn from1
A recent article in the journal, Cell, described the case of a patient who had managed to cure himself of type 1 diabetes using his own modified cell1
Akantior: a recently approved drug for the treatment of acanthamoeba keratitis. The parasite infects the cornea through contact lenses and can cause1
Researchers from the Clínic-IDIBAPS, along with researchers from the Dana Farber Cancer Institute (DFCI) in Boston, have published a review on dual H1
A recent article describes how a new biomaterial has shown promising results in regenerating cartilage. Human studies and long-term results are still1
The Clínic-IDIBAPS has coordinated a study that examines the natural history and the prognostic factors of porto-sinusoidal vascular disorder (PSVD),1
New research reveals how albumin improves B cell function and enhances neutrophil antimicrobial capabilities, reducing infection risk in vulnerable p1